Using Ultrasonography, Shear Wave Elastography, Strain Imaging, & 3-D

Status Withdrawn

Clinical Trial Summary

The researchers are trying to see whether contrast-enhanced ultrasonography, shear wave elastography, strain imaging, and 3-D volume ultrasonography improves arterial wall visualization and identifies arterial elastic properties among individuals with fibromuscular dysplasia (FMD), atherosclerosis, personal history of spontaneous coronary artery dissections (SCAD), or personal history of segmental arterial mediolysis (SAM) that may be different compared to those without the aforementioned conditions.

Clinical Trial Description

Aims, purpose, or objectives:

1. To describe whether contrast-enhanced ultrasonography, strain imaging, and 3-D volume ultrasonography are helpful to characterize affected arteries and improve the imaging of arterial wall among patients with Fibromuscular Dysplasia (FMD) and segmental arterial mediolysis (SAM).

2. Evaluate the arterial elastic properties of individuals with FMD and compare to normal individuals, those with atherosclerosis disease, those with personal history of spontaneous coronary artery dissections (SCAD), and/or personal history of segmental arterial mediolysis (SAM) by elastography.

3. Identification of vulnerable arterial elastic properties using contrast-enhanced ultrasonography, shear wave elastography, strain imaging, and 3-D volume ultrasonography to predict short-term and long-term outcomes among individuals with FMD, normal individuals, those with atherosclerosis disease, those with SCAD, and/or SAM.

4. Develop risk factor profiles and risk score systems of patients undergoing contrast-enhanced ultrasonography, shear wave elastography, strain imaging, and 3-D volume ultrasonography among individuals with FMD, those with atherosclerosis disease, those with personal history of SCAD, and/or personal history of SAM. ;

Study Design

Related Conditions & MeSH terms

Aneurysm, Dissecting
Atherosclerosis
Atherosclerosis of Artery
Fibromuscular Dysplasia
Fibromuscular Dysplasia of Arteries
Segmental Arterial Mediolysis
Spontaneous Coronary Artery Dissection

Clinical Trial Details

NCT number	NCT03335020
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Withdrawn
Phase	Phase 1
Start date	April 1, 2018
Completion date	December 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05040958` - Carotid Atherosclerotic Plaque Load and Neck Circumference
Recruiting	`NCT05680935` - microRNAs in the Diagnosis of Atherosclerotic Plaque Instability	N/A
Recruiting	`NCT04955015` - Associations of Carotid Plaque Characteristics With Brain Perfusion and Cognitive Function in Patients Undergoing CEA
Recruiting	`NCT06091319` - Florbetaben for Imaging of Vascular Amyloid
Recruiting	`NCT06211127` - Safety and Efficacy of Cold Laser Plaque Ablation for Lower Limb Arterial Stenosis and Occlusive Lesions	N/A
Withdrawn	`NCT05908513` - NAC Treatment and Outcomes in Patients With Advanced Atherosclerosis and DM	Phase 1
Suspended	`NCT03928769` - PROGENitors, TELomeres and ARTerial Aging
Not yet recruiting	`NCT04277702` - Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease	Phase 3
Not yet recruiting	`NCT04303546` - VOPITB a New Devices to Determine Peripheral Arterial Stiffness: Validation Study
Completed	`NCT05214872` - The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease
Completed	`NCT02715830` - Randomized Clinical Trial in Bellow-the-knee Angioplasty. Treatment of One or More Than One Artery.	Phase 4
Recruiting	`NCT04758650` - Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis	Phase 2
Completed	`NCT04198896` - The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC)
Completed	`NCT03499496` - Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk
Completed	`NCT05118542` - Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis	Phase 3
Recruiting	`NCT04365062` - Clinical Study of Excimer Laser and Drug Coated Balloon Versus Excimer Laser and Plain Balloon Versus Plain Balloon and Drug Coated Balloon to Treat Femoropopliteal In-stent Restenosis	N/A
Completed	`NCT03962686` - Molecular Mechanisms and Carotid Atherosclerosis
Active, not recruiting	`NCT04666584` - Optimal Predilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis	N/A
Recruiting	`NCT05797376` - Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation	Phase 4
Not yet recruiting	`NCT04303351` - Periodontitis and Atherosclerotic-related Arterial Stenosis

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms